BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34048179)

  • 21. SERUM CYTOKINE OF IL-2, IL-10 AND IL-12 LEVELS IN PATIENTS WITH STOMACH ADENOCARCINOMA.
    Shokrzadeh M; Mohammadpour A; Hoseini V; Abediankenari S; Ghassemi-Barghi N; Tabari YS
    Arq Gastroenterol; 2018; 55(4):385-389. PubMed ID: 30785523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.
    Oh SY; Kwon HC; Kim SH; Jang JS; Kim MC; Kim KH; Han JY; Kim CO; Kim SJ; Jeong JS; Kim HJ
    BMC Cancer; 2008 May; 8():123. PubMed ID: 18452596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced expression of pentraxin-3 in glioblastoma cells correlates with increased invasion and IL8-VEGF signaling axis.
    Wesley UV; Sutton I; Clark PA; Cunningham K; Larrain C; Kuo JS; Dempsey RJ
    Brain Res; 2022 Feb; 1776():147752. PubMed ID: 34906547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
    Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
    Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric Adenocarcinoma.
    Park DJ; Seo AN; Yoon C; Ku GY; Coit DG; Strong VE; Suh YS; Lee HS; Yang HK; Kim HH; Yoon SS
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1508-15. PubMed ID: 26259755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic and Predictive Role of Angiogenic Markers in Non- Small Cell Lung Cancer.
    Keskin S; Kutluk AC; Tas F
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):733-736. PubMed ID: 30909672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.
    Infante M; Allavena P; Garlanda C; Nebuloni M; Morenghi E; Rahal D; Roncalli M; Cavuto S; Pesce S; Monari M; Valaperta S; Montanelli A; Solomon D; Bottoni E; Errico V; Voulaz E; Bossi M; Chiesa G; Passera E; Mantovani A; Alloisio M
    Int J Cancer; 2016 Feb; 138(4):983-91. PubMed ID: 26348770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis.
    Wagenaar JF; Goris MG; Gasem MH; Isbandrio B; Moalli F; Mantovani A; Boer KR; Hartskeerl RA; Garlanda C; van Gorp EC
    J Infect; 2009 Jun; 58(6):425-32. PubMed ID: 19443038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of time-resolved immunofluorometric assays for vascular endothelial growth factor and application on plasma of patients with gastric tumours.
    Sheng SL; Bao SH; Huang G; Wang LM
    Clin Exp Immunol; 2008 Mar; 151(3):459-66. PubMed ID: 18234057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentraxin-3 detected in human saliva shows limited correlation with biomarkers associated with systemic inflammation.
    Wetterö J; Jönsson F; von Löhneysen S; Kristenson M; Garvin P; Sjöwall C
    APMIS; 2021 Jun; 129(6):304-313. PubMed ID: 33811685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentraxin 3 as a new indicator of cardiovascular‑related death in patients with advanced chronic kidney disease.
    Krzanowski M; Krzanowska K; Gajda M; Dumnicka P; Dziewierz A; Woziwodzka K; Litwin JA; Sułowicz W
    Pol Arch Intern Med; 2017 Feb; 127(3):170-177. PubMed ID: 28377558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
    Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
    Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma.
    Huang SP; Wu MS; Wang HP; Yang CS; Kuo ML; Lin JT
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1165-9. PubMed ID: 12453275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of pentraxin 3 in patients with chronic heart failure.
    Kotooka N; Inoue T; Aoki S; Anan M; Komoda H; Node K
    Int J Cardiol; 2008 Oct; 130(1):19-22. PubMed ID: 18045709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of long pentraxin PTX3 in patients with polymyalgia rheumatica.
    Pulsatelli L; Peri G; Macchioni P; Boiardi L; Salvarani C; Cantini F; Mantovani A; Meliconi R
    Clin Exp Rheumatol; 2010; 28(5):756-8. PubMed ID: 20822713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pentraxin 3 is a local inflammatory marker in atrial fibrillation.
    Soeki T; Bando S; Uematsu E; Matsuura T; Niki T; Ise T; Kusunose K; Hotchi J; Ueda Y; Tomita N; Yamaguchi K; Yagi S; Fukuda D; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Shimabukuro M; Sata M
    Heart Vessels; 2014 Sep; 29(5):653-8. PubMed ID: 23979265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive Significance of Serum Level of Vascular Endothelial Growth Factor in Gastric Cancer Patients.
    Wang L; Chang Y; Xu J; Zhang Q
    Biomed Res Int; 2016; 2016():8103019. PubMed ID: 27597973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer.
    Tsirlis TD; Kostakis A; Papastratis G; Masselou K; Vlachos I; Papachristodoulou A; Nikiteas NI
    J Surg Oncol; 2010 Nov; 102(6):699-703. PubMed ID: 20672317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical value of inflammatory biomarkers in coronary artery disease: PTX3 as a new inflammatory marker.
    Guo T; Huang L; Liu C; Shan S; Li Q; Ke L; Cheng B
    Exp Gerontol; 2017 Oct; 97():64-67. PubMed ID: 28778748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.